e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Cardiovascular and metabolic consequences of sleep-disordered breathing
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The importance of RDW in obstructive sleep apnea syndrome.
S. Beyhan Sagmen (Istanbul, Turkey), E. Torun Parmaksiz (Istanbul, Turkey), N. Kiral (Istanbul, Turkey), B. Salepci (Istanbul, Turkey), S. Comert (Istanbul, Turkey)
Source:
International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Session:
Cardiovascular and metabolic consequences of sleep-disordered breathing
Session type:
Thematic Poster
Number:
4323
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Beyhan Sagmen (Istanbul, Turkey), E. Torun Parmaksiz (Istanbul, Turkey), N. Kiral (Istanbul, Turkey), B. Salepci (Istanbul, Turkey), S. Comert (Istanbul, Turkey). The importance of RDW in obstructive sleep apnea syndrome.. 4323
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Frequency and importance of metabolic syndrome in obstructive sleep apnea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 414s
Year: 2006
The influence of obesity in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 295s
Year: 2002
Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
Predictors of obstructive sleep apnea syndrome and metabolic syndrome
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
Masked hypertension and obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2006; 28: Suppl. 50, 416s
Year: 2006
Could obstructive sleep apnea syndrome be a component of metabolic syndrome?
Source: Eur Respir J 2006; 28: Suppl. 50, 414s
Year: 2006
A case of obstructive sleep apnea with brady-tachy syndrome
Source: International Congress 2019 – CCC Sleep and breathing disorders
Year: 2019
The effect of age on findings of obstructive sleep apnea syndrome
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Enuresis in obstructive sleep apnea syndrome patients
Source: Annual Congress 2012 - Sleep apnoea: clinical topics
Year: 2012
The effect of concomitant COPD on obstructive sleep apnea syndrome severity and sleep structure
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
Comorbidities of obstructive sleep apnoea syndrome
Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Year: 2011
The importance of sleep position in treatment planning of patients with obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Assessment of sleep apnoea
Year: 2008
Prevalance and characteristics of overlap syndrome in patients with obstructive sleep apnea
Source: Eur Respir J 2002; 20: Suppl. 38, 574s
Year: 2002
The impact of obstructive sleep apnea syndrome on cardiovascular system in children
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011
Association between obstructive sleep apnea hypopnea and metabolic syndromes
Source: Eur Respir J 2004; 24: Suppl. 48, 692s
Year: 2004
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019
Severe obstructive sleep apnea syndrome and anthropometric characteristics
Source: Eur Respir J 2004; 24: Suppl. 48, 118s
Year: 2004
The economic consequences of snoring, obstructive sleep apnea and obesity hypoventilation syndrome
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Predictors of long-term PAP-adherence in obstructive sleep apnea syndrome
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept